OCUL 8-K 2026-11-09

OCULAR THERAPEUTIX, INC (OCUL) 8-K dated 2026-11-09 — accession 0001104659-26-124151.

OCULAR THERAPEUTIX, INC (OCUL) is a biotechnology company listed on US.

OCUL: Reports Third Quarter 2026 Financial Results and Business Highlights

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported OCUL revenue for 2025-12-31 was $52.0M. Net income was -$265.9M. Revenue was down 18.5% from 2024-12-31 to 2025-12-31. OCUL currently screens at market cap $1.76B.

Not investment advice. The OCUL SEC hub lists recent forms. The stock page is the research view.